Piramal Pharma Limited (NSE:PPLPHARMA)
India flag India · Delayed Price · Currency is INR
190.04
-2.09 (-1.09%)
Aug 14, 2025, 3:30 PM IST

Piramal Pharma Company Description

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally.

The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network.

It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids’ wellness, digestives, women’s health, and hygiene, as well as adult incontinence.

The company was incorporated in 2020 and is based in Mumbai, India.

Piramal Pharma Limited
CountryIndia
Founded2020
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees5,476

Contact Details

Address:
Piramal Ananta
Mumbai, Maharashtra 400 070
India
Phone91 22 3802 3000
Websitepiramalpharma.com

Stock Details

Ticker SymbolPPLPHARMA
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE0DK501011
SIC Code2834

Key Executives

NamePosition
Peter Daniel DeYoungChief Executive Officer of Piramal Global Pharma and Director
Nandini Ajay PiramalExecutive Chairperson
Vivek ValsarajChief Financial Officer and Executive Director
Vinay AgarwalSenior Vice President of Operations
Viral GandhiPresident and Group CIO of Piramal Group
Gagan BoranaHead of Investor Relations and Sustainability
Tanya SanishCompany Secretary and Compliance Officer
Sandeep K. RathodGeneral Counsel
Prashanth M. S.Vice President of Sales
Puneet RajputChief Human Resources Officer